Marco Maugeri
Overview
Explore the profile of Marco Maugeri including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
6246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nawaz M, Heydarkhan-Hagvall S, Tangruksa B, Gonzalez-King Garibotti H, Jing Y, Maugeri M, et al.
Adv Sci (Weinh)
. 2023 Feb;
10(12):e2206187.
PMID: 36806740
Lipid nanoparticles (LNPs) are currently used to transport functional mRNAs, such as COVID-19 mRNA vaccines. The delivery of angiogenic molecules, such as therapeutic VEGF-A mRNA, to ischemic tissues for producing...
2.
Bost J, Barriga H, Holme M, Gallud A, Maugeri M, Gupta D, et al.
ACS Nano
. 2021 Oct;
15(11):18590-18591.
PMID: 34714048
No abstract available.
3.
Bost J, Barriga H, Holme M, Gallud A, Maugeri M, Gupta D, et al.
ACS Nano
. 2021 Sep;
15(9):13993-14021.
PMID: 34505766
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list of FDA-approved ON therapies has rapidly expanded. ONs are small (15-30 bp) nucleotide-based therapeutics which are...
4.
Kopparapu P, Deshmukh M, Hu Z, Mohammad M, Maugeri M, Gotz F, et al.
Int J Mol Sci
. 2021 Jul;
22(13).
PMID: 34281154
(), a Gram-positive bacteria, is known to cause various infections. Extracellular vesicles (EVs) are a heterogeneous array of membranous structures secreted by cells from all three domains of life, i.e.,...
5.
Maugeri M, Nawaz M, Papadimitriou A, Angerfors A, Camponeschi A, Na M, et al.
Nat Commun
. 2019 Sep;
10(1):4333.
PMID: 31551417
RNA-based therapeutics hold great promise for treating diseases and lipid nanoparticles (LNPs) represent the most advanced platform for RNA delivery. However, the fate of the LNP-mRNA after endosome-engulfing and escape...
6.
Vallelunga A, Iannitti T, Dati G, Capece S, Maugeri M, Tocci E, et al.
Mol Biol Rep
. 2019 Feb;
46(2):1661-1666.
PMID: 30810945
Multiple system atrophy (MSA) is a neurodegenerative disease that belongs to the α synucleinopathies. Clinically, there is an overlap between MSA and Parkinson's disease (PD), especially at the early disease...
7.
Thery C, Witwer K, Aikawa E, Alcaraz M, Anderson J, Andriantsitohaina R, et al.
J Extracell Vesicles
. 2019 Jan;
7(1):1535750.
PMID: 30637094
The last decade has seen a sharp increase in the number of scientific publications describing physiological and pathological functions of extracellular vesicles (EVs), a collective term covering various subtypes of...
8.
Nawaz M, Shah N, Zanetti B, Maugeri M, Silvestre R, Fatima F, et al.
Cells
. 2018 Oct;
7(10).
PMID: 30322133
Extracellular vesicles (EVs) are membrane enclosed micro- and nano-sized vesicles that are secreted from almost every species, ranging from prokaryotes to eukaryotes, and from almost every cell type studied so...
9.
Statello L, Maugeri M, Garre E, Nawaz M, Wahlgren J, Papadimitriou A, et al.
PLoS One
. 2018 Apr;
13(4):e0195969.
PMID: 29689087
The RNA that is packaged into exosomes is termed as exosomal-shuttle RNA (esRNA); however, the players, which take this subset of RNA (esRNA) into exosomes, remain largely unknown. We hypothesized...
10.
Fatima F, Ekstrom K, Nazarenko I, Maugeri M, Valadi H, Hill A, et al.
Front Genet
. 2017 Nov;
8:161.
PMID: 29123544
Extracellular vesicles (EVs) are heterogeneous populations of nano- and micro-sized vesicles secreted by various cell types. There is mounting evidence that EVs have widespread roles in transporting proteins, lipids, and...